Fingerprint
Dive into the research topics of 'Survival update from a phase II trial of fulvestrant ('Faslodex®') in tamoxifen-resistant breast cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Survival update from a phase II trial of fulvestrant ('Faslodex®') in tamoxifen-resistant breast cancer patients
J. F.R. Robertson, A. Howell, R. Owers, K. L. Cheung
Research output: Contribution to journal › Article › peer-review